Evidence map›Paper›PMID 41551848›Full record

ArticleIJID regions2026

Survival after cardiopulmonary arrest due to Capnocytophaga canimorsus sepsis: A case successfully managed using plasma exchange.

Yoshio Nakano, Hiroka Serizawa, Iwao Gohma

Abstract readCase Reports
In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoshio NakanoDepartment of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan.
Hiroka SerizawaDepartment of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan.
Iwao GohmaDepartment of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capnocytophaga canimorsus sepsis is potentially fatal, even in immunocompetent hosts. This report describes a case involving a 57-year-old woman, who developed fever after a dog bite and initially presented without an evident focus. On the day of admission, she deteriorated to pulseless electrical activity during transport and achieved return of spontaneous circulation after approximately 23 minutes of resuscitation. Broad-spectrum antimicrobials (meropenem) were initiated for septic shock, and Capnocytophaga canimorsus subsequently grew in both the pre-admission and admission blood cultures. Peripheral discoloration suggested purpura fulminans. A precipitous decline in platelet count, schistocytosis, elevated lactate dehydrogenase levels, and acute kidney injury fulfilled the criteria for thrombotic microangiopathy, whereas ADAMTS13 activity was normal. Intensive care consisted of red blood cell and platelet transfusions, continuous hemodiafiltration transitioning to intermittent hemodialysis, mechanical ventilation with tracheostomy, and therapeutic plasma exchange once daily for three sessions. Hematological abnormalities resolved, schistocytes disappeared, organ dysfunction improved, and she was ultimately removed from ventilation and dialysis with full neurological recovery. This report describes survival after cardiopulmonary arrest due to Capnocytophaga canimorsus sepsis and suggests that plasma exchange may be a useful adjunct for secondary thrombotic microangiopathy in this setting. Early diagnosis, prompt antibiotic treatment, and multidisciplinary critical care are essential.

Indexed as

Capnocytophaga canimorsusCardiopulmonary arrestCritical carePlasma exchangeSepsisThrombotic microangiopathy

Identifiers

PMID41551848
PMCPMC12809399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.